New York, NY -- (SBWIRE) -- 05/21/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Xenoport, Inc. (NASDAQ:XNPT), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and The Spectranetics Corporation ...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares declined 3.89% and closed at $13.83. The company, on May 20, announced that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock.

Ironwood Pharmaceuticals Inc. (IRWD: Quote) announced after the bell Monday that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common stock.

(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the pricing of an underwritten public offering of 10,500,000 shares of its Class A common stock at a price of $13.00 per share to the public.

Ironwood Pharmaceuticals (NASDAQ: IRWD) is committed to the art and science of making medicines, from discovery through commercialization.

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD): In Thursday's trading session, Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) dropped 3.12%. Its opening price of $15.01 was also the intraday high, which eventually headed down to close at $14.60 per ...

Ironwood Pharmaceuticals Inc.'s (IRWD) first-quarter loss widened more than Wall Street expected as the drug maker posted a sharp rise in operating expenses.

New York, NY -- (SBWIRE) -- 04/24/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Cell Therapeutics, Inc. (NASDAQ:CTIC), and Exact Sciences Corporation ...

Wilmington, DE -- (SBWIRE) -- 04/23/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding IDEXX Laboratories, Inc. (NASDAQ:IDXX), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and Achillion Pharmaceuticals, Inc.

New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Exact Sciences Corporation (NASDAQ:EXAS), and Ironwood Pharmaceuticals, Inc.